Successful treatment with inhaled corticosteroid/long-acting β2-agonist in a case of allergic bronchopulmonary mycosis caused by Schizophyllum commune

• Published in: Respiratory medicine case reports Vol. 46; p. 101935
• Main Authors: Sekiya, Muneyuki, Sakamoto, Susumu, Sekiguchi, Ryo, Sadamoto, Sota, Sasaki, Masakazu, Kamei, Katsuhiko, Shibuya, Kazutoshi, Kishi, Kazuma
• Format: Journal Article
• Language: English
• Published: Elsevier 2023
• Subjects: Allergic bronchopulmonary mycosis; High-attenuation mucus; Inhaled corticosteroid/long-acting β2-agonist; Schizophyllum commune

Allergic bronchopulmonary mycosis (ABPM) is a chronic immune-mediated pulmonary disease, which is caused by fungal infection of the airways. Aspergillus species are the main causative fungi and standard treatment typically comprises systemic corticosteroid therapy with or without adjunct antifungal...